Received Mar 17, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | YA3NL | IM / RA |
Pt states soreness and recurring infection in the exact area where pt received shingles vaccine, starting after administration.
N/A
N/A
N/A
NKDA
N/A